share_log

KP Tissue Announces Senior Unsecured Notes Financing and Intention to Redeem 6.00% Notes Due April 2025

KP Tissue Announces Senior Unsecured Notes Financing and Intention to Redeem 6.00% Notes Due April 2025

KP Tissue宣佈發行無抵押高級票據融資,並打算贖回於2025年4月到期的6.00%票據
GlobeNewswire ·  10/26 07:06

NOT FOR DISTRIBUTION TO NEWSWIRE SERVICES IN U.S. OR FOR DISSEMINATION IN U.S.

不得向美國新聞社或在美國傳播。

MISSISSAUGA, Ontario, Oct. 25, 2024 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) announced today that Kruger Products Inc. ("KPI") has, pursuant to an underwriting agreement entered into today, agreed to issue and sell CDN $135 million principal amount of 6.625% Senior Unsecured Notes (the "Notes") due November 1, 2031 by way of private placement (the "Offering"). Interest on the Notes is payable semi-annually in arrears on May 1 and November 1 of each year, commencing on May 1, 2025.

安大略省密西沙加,2024年10月25日(環球新聞社) - KP Tissue Inc.(KPT)(TSX:KPT)今天宣佈,Kruger Products Inc.(「KPI」)已根據今天簽訂的承銷協議同意發行和賣出加元$13500萬的6.625%未擔保高級票據(「票據」),到期日爲2031年11月1日,通過定向增發(「發行」)。票據的利息每年5月1日和11月1日按年付息。2025年5月1日起計息。

Scotia Capital Inc., National Bank Financial Inc., CIBC Capital Markets Inc. and TD Securities Inc. are acting as joint book-running managers for the Offering. The Offering is expected to close on November 1, 2024, subject to customary closing conditions. KPI intends to use the net proceeds of the Offering to redeem all of KPI's outstanding 6.00% senior unsecured notes due April 24, 2025 (the "2025 Notes") and for general corporate purposes. KPI intends to deliver today a notice of redemption of the 2025 Notes with a redemption date of November 12, 2024 subject to the closing of the Offering prior to that date.

Scotia Capital Inc.、national bank、CIBC Capital Markets Inc.和TD Securities Inc.將作爲本次發行的聯席主承銷商。該發行預計將於2024年11月1日結束,視情況而定。KPI打算使用本次發行的淨收益贖回KPI尚未償還的6.00%到期於2025年4月24日的未擔保高級票據(「2025年票據」),並用於一般企業用途。KPI打算今天發佈2025年票據的贖回通知,贖回日期爲2024年11月12日,視發行截止日是否早於該日期而定。

The Notes will be unsecured obligations of KPI and unconditionally guaranteed, jointly and severally, by certain subsidiaries of KPI, being the same guarantors as under KPI's syndicated credit facility. The Notes will rank senior in right of payment to all existing and future subordinated indebtedness of KPI and equal in right of payment to all indebtedness of KPI that is not subordinated in right of payment to the Notes other than any indebtedness that ranks senior to the Notes by operation of law.

票據將爲KPI的無擔保債務,由KPI的某些子公司共同且無條件擔保。這些子公司與KPI的銀團信貸機構一樣擔保。票據將在支付權利上優於KPI現有和未來的所有次級債務,並在支付權利上與所有不作爲票據次級債務的KPI債務平齊,除了根據法律規定優先於票據的任何債務。

The offer and sale of the Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), or applicable state securities laws, and the Notes may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws. The Notes have not been and will not be qualified for sale to the public under applicable Canadian securities laws and, accordingly, any offer and sale of the Notes in Canada will be made on a basis exempt from the prospectus requirements of such securities laws.

票據的發行和銷售未受到並將不受到根據1933年修正案("證券法")以及適用州證券法進行註冊,並且未經註冊或具有適用的豁免登記要求的情況下,不得在美國提供或銷售票據或適用的州證券法。票據未經過且不會符合根據適用的加拿大證券法向公衆銷售的資格,因此,在加拿大對票據的任何提供和銷售將在免於此類證券法的概要要求的基礎上進行。

This news release does not constitute an offer to sell or purchase, or a solicitation of an offer to sell or purchase, the Notes. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such offer, solicitation, purchase or sale would be unlawful. This news release does not constitute a notice of redemption of the 2025 Notes.

本新聞稿不構成要約出售或購買,或要約出售或購買票據,也不構成要約出售或購買的邀請。在任何此類要約、邀請、購買或銷售將是非法的司法管轄區中,將不會進行任何要約、邀請、購買或銷售。本新聞稿不構成2025票據贖回通知。

About KP Tissue Inc.
KPT was created to acquire, and its business is limited to holding, a limited equity interest in KPI, which is accounted for as an investment on the equity basis. KPT currently holds a 12.56% interest in KPI. For more information visit .

關於KP Tissue Inc.
KPt成立旨在收購,並且其業務僅限於持有KPI的有限股權,KPI被按照權益法上的投資進行覈算。KPt目前持有KPI的12.56%的股權。欲了解更多信息,請訪問。

About Kruger Products Inc.
KPI is Canada's leading manufacturer of quality tissue products for household, industrial and commercial use. KPI serves the Canadian consumer market with such well-known brands as Cashmere, Purex, SpongeTowels, Scotties, White Swan and Bonterra. In the U.S., KPI manufactures the White Cloud brand, as well as many private label products. The Away-From-Home division manufactures and distributes high-quality, cost-effective product solutions to a wide range of commercial and public entities. KPI has approximately 2,800 employees and operates ten FSC COC-certified (FSC C-104904) production facilities in North America. For more information visit .

關於Kruger Products Inc.
KPI是加拿大領先的生產優質家庭、工業和商業用紙產品的製造商。KPI以Cashmere、Purex、SpongeTowels、Scotties、White Swan和Bonterra等知名品牌服務加拿大消費市場。在美國,KPI生產White Cloud品牌,以及許多自有品牌產品。離家使用部門向各種商業和公共機構提供高質量、具有成本效益的產品解決方案。KPI擁有約2,800名員工,並在北美運營十家FSC COC認證(FSC C-104904)生產設施。欲了解更多信息,請訪問。

Forward Looking Information
Certain information included herein is forward looking, within the meaning of applicable Canadian securities laws. Such information is typically identified by words such as "anticipate", "believe", "could", "estimate", "expect", "plan", "intend", "forecast", "future", "guidance", "may", "predict", "project", "should", "strategy", "target", "will" or similar expressions suggesting future outcomes. Forward looking information in this news release includes the expected closing date of the Offering, the use of net proceeds of the Offering, the delivery of a notice of redemption of the 2025 Notes and the expected redemption date. KPT believes the expectations reflected in such forward looking information are reasonable, but no assurance can be given that these expectations will prove to be correct, and such information should not be unduly relied upon.

前瞻性信息
此處包含的部分信息屬於前瞻性信息,符合適用加拿大證券法的含義。此類信息通常由諸如"預計"、"相信"、"可能"、"估計"、"期望"、"計劃"、"打算"、"預測"、"未來"、"指導"、"可能"、"預測"、"計劃"、"策略"、"目標"、"將"等詞語識別,暗示未來結果。本新聞稿中的前瞻性信息包括定向增發的預期截止日期、定向增發淨收益的使用、2025年債券贖回通知的交付以及預期贖回日期。KPt相信,此類前瞻性信息所反映的期望是合乎情理的,但不能保證這些期望將被證明是正確的,因此不應過分依賴此類信息。

Forward looking information is not a guarantee of future performance. By its very nature, forward looking information involves inherent assumptions, risks and uncertainties, both general and specific, and risks that predictions, forecasts, projections and other forward looking information will not be achieved. These risks include, but are not limited to, risks associated with the ability to satisfy the closing conditions of the Offering. Should one or more of these risks and uncertainties materialize, or should assumptions described above prove incorrect, KPT's actual performance and results in future periods may differ materially from any projections of future performance or results expressed in or implied by such forward looking information. We caution readers not to place undue reliance on such information as a number of important factors could cause the actual results to differ materially from the beliefs, plans, objectives, expectations and anticipations, estimates and intentions expressed in such forward looking information.

前瞻性信息並非未來業績的保證。由於其本質,前瞻性信息涉及固有的假設、一般和特定風險和不確定性,以及預測、展望、投影和其他前瞻性信息將無法實現的風險。這些風險包括但不限於與滿足定向增發的關閉條件的風險相關聯。如果其中一個或多個風險和不確定性實現,或者上述假設被證明不正確,KPT未來期間的實際業績和結果可能會與前瞻性信息中表達或暗示的任何未來業績或結果的預測實質上不同。我們提醒讀者不要過分依賴此類信息,因爲許多重要因素可能導致實際結果與前瞻性信息中表達的信念、計劃、目標、期望和預期、估計和意圖實質上不同。

Forward looking information contained in this news release is provided for the purpose of providing information about management's goals, plans and range of expectations for the future and may not be appropriate for other purposes. Any forward looking information is made as of the date hereof and, except as required by law, KPT does not undertake any obligation to publicly update or revise such information to reflect new information, subsequent or otherwise.

本新聞稿中包含的前瞻性信息旨在提供有關管理層目標、計劃和未來預期範圍的信息,可能不適用於其他目的。任何前瞻性信息均截至本日期發佈,並且除非法律要求,KPt不承擔公開更新或修訂此類信息以反映新信息的義務。

INFORMATION: INVESTORS:
François Paroyan Doris Grbic
General Counsel and Corporate Secretary Director, Investor Relations
KP Tissue Inc. KP Tissue Inc.
905-812-6936 905-813-5063
francois.paroyan@krugerproducts.ca ir@krugerproducts.ca
信息: 投資者:
François Paroyan Doris Grbic
總法律顧問兼公司秘書。 投資者關係董事
KP Tissue Inc. KP Tissue Inc.
905-812-6936 905-813-5063
francois.paroyan@krugerproducts.ca ir@krugerproducts.ca

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論